Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Adherens junction 💬
[1] FGFR1 💬 Infigratinib 💬 Infigratinib [1] 276 💬
2 Adherens junction 💬
[1] FGFR1 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
3 Breast cancer 💬
[1] FGFR1 💬 Infigratinib 💬 Infigratinib [1] 276 💬
4 Breast cancer 💬
[2] FGFR1, FLT4 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
5 Calcium signaling pathway 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
6 Calcium signaling pathway 💬
[8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
7 Central carbon metabolism in cancer 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
8 Central carbon metabolism in cancer 💬
[5] FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
9 MAPK signaling pathway 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
10 MAPK signaling pathway 💬
[8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
11 Melanoma 💬
[1] FGFR1 💬 Infigratinib 💬 Infigratinib [1] 276 💬
12 Melanoma 💬
[3] FGFR1, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
13 Parathyroid hormone synthesis, secretion and action 💬
[1] FGFR1 💬 Infigratinib 💬 Infigratinib [1] 276 💬
14 Parathyroid hormone synthesis, secretion and action 💬
[1] FGFR1 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
15 Pathways in cancer 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
16 Pathways in cancer 💬
[6] FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
17 PI3K-Akt signaling pathway 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
18 PI3K-Akt signaling pathway 💬
[8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
19 Prostate cancer 💬
[2] FGFR1, FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
20 Prostate cancer 💬
[4] FGFR1, FGFR2, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
21 Proteoglycans in cancer 💬
[1] FGFR1 💬 Infigratinib 💬 Infigratinib [1] 276 💬
22 Proteoglycans in cancer 💬
[2] FGFR1, KDR 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
23 Rap1 signaling pathway 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
24 Rap1 signaling pathway 💬
[8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
25 Ras signaling pathway 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
26 Ras signaling pathway 💬
[8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
27 Regulation of actin cytoskeleton 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
28 Regulation of actin cytoskeleton 💬
[5] FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
29 Signaling pathways regulating pluripotency of stem cells 💬
[3] FGFR1, FGFR2, FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
30 Signaling pathways regulating pluripotency of stem cells 💬
[3] FGFR1, FGFR2, FGFR3 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
31 Thermogenesis 💬
[1] FGFR1 💬 Infigratinib 💬 Infigratinib [1] 276 💬
32 Thermogenesis 💬
[1] FGFR1 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬